While diminished expression levels of FCGBP have been noted in gallbladder and prostate cancers [14, 15], contrasting observations reveal elevated FCGBP expression in glioma, hepatocellular carcinoma, and ovarian cancer [16–18]. Here, FCGBP is linked to prostate cancer.